Lead Product(s) : Diquafosol Sodium
Therapeutic Area : Ophthalmology
Study Phase : Phase II
Sponsor : Santen Pharmaceutical
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Diquafosol Sodium is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Dry Eye Syndromes.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 27, 2023
Lead Product(s) : Diquafosol Sodium
Therapeutic Area : Ophthalmology
Highest Development Status : Phase II
Sponsor : Santen Pharmaceutical
Deal Size : Inapplicable
Deal Type : Inapplicable